Lead and deliver imaging endpoints from Ph1 to Ph4 assets across Respiratory, Immunology, Hepatology, GI, Renal and Dermatology indications
Facilitate selection of optimal imaging endpoints for GSK studies, and application and delivery in multicentre studies
Resource the studies appropriately to ensure high-quality imaging data & support initiatives to enable data reuse
Assist with developing a Clinical Imaging strategy for addressing GSK’s emerging disease areas of interest and adjust the strategy according to pipeline changes
Lead on capability development initiatives, including deep analysis of imaging datasets for biomarker development to deliver on internal needs, including disease subclassification, prognostics and treatment response
Requirements
BSc or PhD (or equivalent) in relevant biomedical, life science, medical imaging or related field of study
Experience in clinical imaging using multiple radiological imaging modalities (e.g. CT, PET, MRI)
Experience in clinical research working within an imaging CRO, within a large pharmaceutical company, or experience in clinical imaging via a post doc
Direct experience in leading and delivering imaging-endpoints within clinical trials (phase 1-4)
Detailed experience across the lifecycle of multicentre studies delivering standard, regulatory; AND advanced, non-regulatory imaging endpoints across multiple therapeutic areas
Benefits
Competitive salary
Annual bonus based on company performance
Healthcare and wellbeing programmes
Pension plan membership
Shares and savings programme
Hybrid working model
Applicant Tracking System Keywords
Tip: use these terms in your resume and cover letter to boost ATS matches.